Irradiation potentiates p53 phosphorylation and p53 binding to the promoter and coding region of the TP53 gene

被引:2
|
作者
Legartova, Sona [1 ]
Fagherazzi, Paolo [1 ,2 ]
Goswami, Pratik [3 ,5 ]
Brazda, Vaclav [3 ]
Lochmanova, Gabriela [4 ,5 ]
Koutna, Irena [6 ]
Bartova, Eva [1 ]
机构
[1] Acad Sci Czech Republ, Inst Biophys, Dept Cell Biol & Epigenet, Brno, Czech Republic
[2] Masaryk Univ, Fac Sci, Dept Expt Biol, Brno, Czech Republic
[3] Acad Sci Czech Republ, Inst Biophys, Dept Biophys Chem & Mol Oncol, Brno, Czech Republic
[4] Masaryk Univ, Cent European Inst Technol, Brno, Czech Republic
[5] Masaryk Univ, Fac Sci, Natl Ctr Biomol Res, Brno, Czech Republic
[6] St Annes Univ Hosp Brno FNUSA, Int Clin Res Ctr ICRC, Pekarska 53, Brno 65691, Czech Republic
关键词
p53; 53BP1; DNA damage; Epigenetics; Mass spectrometry; FLIM-FRET; AFM; NUCLEOTIDE EXCISION-REPAIR; STRAND BREAK REPAIR; DNA-DAMAGE; TUMOR-SUPPRESSOR; POSTTRANSLATIONAL MODIFICATION; HOMOLOGOUS RECOMBINATION; OLIGOMERIZATION DOMAIN; CAENORHABDITIS-ELEGANS; GAMMA-IRRADIATION; WILD-TYPE;
D O I
10.1016/j.biochi.2022.09.013
中图分类号
Q5 [生物化学]; Q7 [分子生物学];
学科分类号
071010 ; 081704 ;
摘要
An essential factor of the DNA damage response is 53BP1, a multimeric protein that inhibits the resection-dependent double-strand break (DBS) repair. The p53 protein is a tumor suppressor known as a guardian of the genome. Although the interaction between 53BP1 and its p53 partner is well-known in regulating gene expression, a question remains whether genome injury can affect the interaction be-tween 53BP1 and p53 proteins or p53 binding to DNA. Here, using mass spectrometry, we determine post-translational modifications and interaction properties of 53BP1 and p53 proteins in non-irradiated and y-irradiated cells. In addition, we used Atomic Force Microscopy (AFM) and Fluorescent Lifetime Imaging Microscopy combined with Fluorescence Resonance Energy Transfer (FLIM-FRET) for studies of p53 binding to DNA. Also, we used local laser microirradiation as a tool of advanced confocal microscopy, showing selected protein accumulation at locally induced DNA lesions. We observed that 53BP1 and p53 proteins accumulate at microirradiated chromatin but with distinct kinetics. The density of 53BP1 (53BP1pS1778) phosphorylated form was lower in DNA lesions than in the non-specified form. By mass spectrometry, we found 22 phosphorylations, 4 acetylation sites, and methylation of arginine 1355 within the DNA-binding domain of the 53BP1 protein (aa1219-1711). The p53 protein was phosphory-lated on 8 amino acids and acetylated on the N-terminal domain. Post-translational modifications (PTMs) of 53BP1 were not changed in cells exposed to y-radiation, while y-rays increased the level of S6ph and S15ph in p53. Interaction analysis showed that 53BP1 and p53 proteins have 54 identical interaction protein partners, and AFM revealed that p53 binds to both non-specific and TP53-specific sequences (AGACATGCCTA GGCATGTCT). Irradiation by y-rays enhanced the density of the p53 protein at the AGACATGCCTAGGCATGTCT region, and the binding of p53 S15ph to the TP53 promoter was potentiated in irradiated cells. These findings show that y-irradiation, in general, strengthens the binding of phos-phorylated p53 protein to the encoding gene.(c) 2022 Elsevier B.V. and Societe Francaise de Biochimie et Biologie Moleculaire (SFBBM). All rights reserved.
引用
收藏
页码:154 / 168
页数:15
相关论文
共 50 条
  • [1] P53/Tp53 status in keratoacanthomas
    Joshi, S.
    Schjolberg, A.
    De Angelis, P. M.
    Ekstrom, P. O.
    Clausen, O. P.
    VIRCHOWS ARCHIV, 2015, 467 : S48 - S48
  • [2] Tp53/p53 status in keratoacanthomas
    Joshi, Sarita
    Schjolberg, Aasa R.
    Ekstrom, Per Olaf
    De Angelis, Paula M.
    Zucknick, Manuela
    Andersen, Solveig Norheim
    Clausen, Ole Petter F.
    JOURNAL OF CUTANEOUS PATHOLOGY, 2016, 43 (07) : 571 - 578
  • [3] Expression of TP53 Isoforms p53β or p53γ Enhances Chemosensitivity in TP53null Cell Lines
    Silden, Elisabeth
    Hjelle, Sigrun M.
    Wergeland, Line
    Sulen, Andre
    Andresen, Vibeke
    Bourdon, Jean-Christophe
    Micklem, David R.
    McCormack, Emmet
    Gjertsen, Bjorn Tore
    PLOS ONE, 2013, 8 (02):
  • [4] BSTNI/NCII POLYMORPHISM OF THE HUMAN P53 GENE (TP53)
    CHUMAKOV, PM
    JENKINS, JR
    NUCLEIC ACIDS RESEARCH, 1991, 19 (24) : 6969 - 6969
  • [5] Demonstration of p53 protein and TP53 gene mutations in oligodendrogliomas
    Hagel, C
    Laking, G
    Laas, R
    Scheil, S
    Jung, R
    MildeLangosch, K
    Stavrou, DK
    EUROPEAN JOURNAL OF CANCER, 1996, 32A (13) : 2242 - 2248
  • [6] Modulation of p53β and p53γ expression by regulating the alternative splicing of TP53 gene modifies cellular response
    Marcel, V.
    Fernandes, K.
    Terrier, O.
    Lane, D. P.
    Bourdon, J-C
    CELL DEATH AND DIFFERENTIATION, 2014, 21 (09): : 1377 - 1387
  • [7] Modulation of p53β and p53γ expression by regulating the alternative splicing of TP53 gene modifies cellular response
    V Marcel
    K Fernandes
    O Terrier
    D P Lane
    J-C Bourdon
    Cell Death & Differentiation, 2014, 21 : 1377 - 1387
  • [8] Accumulation of p53 protein in pterygia is not accompanied by TP53 gene mutation
    Schneider, BG
    John-Aryankalayil, M
    Rowsey, JJ
    Dushku, N
    Reid, TW
    EXPERIMENTAL EYE RESEARCH, 2006, 82 (01) : 91 - 98
  • [9] TP53 gene and p53 protein vs. endometrial carcinoma
    Zajac, Agnieszka
    Stachowiak, Grzegorz
    Stetkiewicz, Tomasz
    Wilczynski, Jacek R.
    MENOPAUSE REVIEW-PRZEGLAD MENOPAUZALNY, 2013, 12 (03): : 228 - 230
  • [10] Focus on the p53 gene and cancer:: Advances in TP53 mutation research
    Soussi, T
    HUMAN MUTATION, 2003, 21 (03) : 173 - 175